StonvexLoading…
StonvexStonvexStonvexCore line items from BTMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $44.94M | $192.22M | $145.81M | $97.86M |
Operating Income | $3.17M | $35.55M | $28.72M | $20.45M |
Net Income | $2.28M | $27.05M | $25.09M | $16.90M |
EPS (Diluted) | $0.06 | $0.74 | $0.68 | $0.46 |
Total Assets | $89.03M | $107.61M | $111.32M | $104.80M |
Total Liabilities | $136.99M | $158.01M | $176.79M | $183.64M |
Cash & Equivalents | $5.32M | $24.12M | $28.05M | $19.60M |
Free Cash Flow OCF − CapEx | $3.54M | $30.18M | $23.69M | $10.11M |
Shares Outstanding | 36.00M | 36.67M | 36.87M | 36.96M |